论文部分内容阅读
作者分析18年中218例非白血病性慢性骨髓增殖性疾患(CMPD)患者的寿命表生存可能性(ac-tuarial probability)和主要特征.218例CMPD 中包括真性红细胞增多症(PV)91例,原发性骨髓纤维化(IM)70例和原发性血小板增多症(ET)57例。结果PV 患者中数随访期68(范围1—184)月中11例死亡,预计10年生存率为68.7%,95%置信限(CT)48.1～89.3%,而IM 中34例死亡,中数生存期59(范围1—119)月。中数随访期26(范围4—118)月
The authors analyzed the life-table ac-tuarial probability and major characteristics in 218 patients with non-leukemic chronic myeloproliferative disorder (CMPD) over 18 years, including 91 cases of polycythemia vera (PV) in 218 cases of CMPD, 70 cases of primary myelofibrosis (IM) and 57 cases of essential thrombocythemia (ET). Results The median number of PV patients was 11 during the follow-up period of 68 (range 1-184), with a 10-year survival rate of 68.7% and a 95% confidence interval (CT) of 48.1-89.3%, while 34 of IM patients died, median Survival 59 (range 1-119) month. The median follow-up period 26 (range 4-118) months